
Health.Market February 22, 2021
I think the main thing to worry about is whether or not we should be worried. As previously noted either continuation of prior trends or
I think the main thing to worry about is whether or not we should be worried. As previously noted either continuation of prior trends or
This week saw an echo continuation of the prior week’s extremely strong bullish move. There were no specific changes in trends except perhaps the VIX
Big tech earnings, fiscal stimulus, vaccines conspired to rally stocks. Tech and SMIDs drove the gains. Stocks + Treasuries + US dollar + commodities +
The market made a rapid reversal that has weakened the short-term upward trend in the indexes. The significance of GME while entertaining is still conjectural.
US equities hit new highs on most of the indexes. Upward momentum is waning and the internal market dynamics are corrective in nature. Biotechnology firms
The US equities are trying to deal with so much liquidity and an extreme bullish sentiment that we are just sloshing and whooshing. Good for
Last week for stocks was more or less a continuation of what had happened from November onward. One hopes with resolution of some things we
Activity is slowing down and continuation patterns proliferate. NDX is more bullish than SPX. SPX sectors are sideways to mild correction except XLK, XLY +/-
The evolution of thought from his own business experience with three startups and numerous leadership roles in others led to the basis of Green Room’s
Momentum declined last week and with net bullish sentiment is not a great setup for further gains short term. The indexes are overbought but not
PO Box 637
Austin, Texas
[email protected]
By providing your contact information you consent to receiving emails & information from Green Room Technologies.
No Spam. We respect your privacy & you may unsubscribe at any time.